Are we ready for disease modification in myeloproliferative neoplasms?
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-09-01
|
| Series: | HemaSphere |
| Online Access: | https://doi.org/10.1002/hem3.70003 |
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-09-01
|
| Series: | HemaSphere |
| Online Access: | https://doi.org/10.1002/hem3.70003 |